奈敏维联合思然治疗视频终端综合征眼部症状的临床疗效

发布时间：2018-05-07 06:02

本文选题：奈敏维滴眼液 + 思然滴眼液　；参考：《海峡药学》2016年12期

【摘要】：目的探讨奈敏维联合思然滴眼液治疗视频终端综合征眼部症状的疗效。方法收集2014年6月至2015年12月在我院接受治疗的90例视频终端综合征眼部症状患者为研究对象,采用随机分配的方法将其分为观察组(n=45例)与对照组(n=45例),对照组采用查敏维滴眼液进行治疗,观察组在对照组基础上加入思然滴眼液治疗,两组治疗疗程均为30d,观察两组患者眼痛、异物感、干涩等指标改善情况。结果观察组(95.56%)治疗效果明显优于对照组(73.33%),观察组干涩(0.39±0.45)、异物感(0.17±0.25)、眼痛(0.31±0.42)等评分明显低于对照组(1.33±0.57、1.42±0.48、2.37±0.62),组间数据对比差异显著(P0.05)。结论视频终端综合征眼部症状患者给予奈敏维联合思然滴眼液治疗,能有效缓解视疲劳症状,提高临床治疗效果,值得在临床上大力推广应用。
[Abstract]:Objective to investigate the effect of NaMinwei combined with siran eye drops on ocular symptoms of video terminal syndrome. Methods from June 2014 to December 2015, 90 patients with visual terminal syndrome who were treated in our hospital were studied. It was randomly divided into observation group (n = 45) and control group (n = 45). The control group was treated with Cha Min's eye drops, and the observation group was treated with siran eye drops on the basis of the control group. The two groups were treated for 30 days. The improvement of eye pain, foreign body sensation and dryness were observed. Results the therapeutic effect of the observation group was significantly better than that of the control group (73.33). The scores of dry and astringent, foreign body sensation, eye pain and eye pain in the observation group were 0.39 卤0.45, 0.17 卤0.25 and 0.31 卤0.42), respectively, which were significantly lower than those in the control group (1.33 卤0.57-1.42 卤0.482.37 卤0.62P), and the difference between the two groups was significant (P 0.05). Conclusion the patients with visual terminal syndrome can be treated with NaMinwei combined with siran eye drops, which can effectively relieve the symptoms of visual fatigue and improve the effect of clinical treatment. It is worth popularizing and applying in clinic.
【作者单位】：福建省漳州市人民医院眼科;
【分类号】：R77

【相似文献】